NCT06528964View on ClinicalTrials.gov

Proteinopathies Expression in Skin of Neurodegenerative Disorders

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

October 25, 2026

Study Completion Date

November 1, 2026

Conditions
Alzheimer DiseaseFrontotemporal DementiaParkinson DiseaseAtypical ParkinsonismAmyotrophic Lateral SclerosisNormal Pressure Hydrocephalus
Interventions
DIAGNOSTIC_TEST

Immunohistochemistry and immunofluorescence

Skin biopsies will be analyzed using immunohistochemistry and immunofluorescence to detect the presence of aggregated a-synuclein, amyloid-b, p-TAU and TDP-43.

Trial Locations (1)

78290

RECRUITING

Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí City

All Listed Sponsors
collaborator

"Hospital Central Dr. Ignacio Morones Prieto"

OTHER

lead

Universidad Autonoma de San Luis Potosí

OTHER